2000
DOI: 10.1016/s1383-5718(00)00022-x
|View full text |Cite
|
Sign up to set email alerts
|

Comparing the genotoxic sensitivities of human peripheral blood lymphocytes and mucosa cells of the upper aerodigestive tract using the Comet assay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
11
0
2

Year Published

2003
2003
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(14 citation statements)
references
References 17 publications
1
11
0
2
Order By: Relevance
“…Consequently, the group considered unstimulated mucosa cells from fresh biopsy samples. The use of mucosa cells has previously been described with only minor changes to original lymphocyte protocol (12) and has been published earlier (15,29).…”
Section: A B Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Consequently, the group considered unstimulated mucosa cells from fresh biopsy samples. The use of mucosa cells has previously been described with only minor changes to original lymphocyte protocol (12) and has been published earlier (15,29).…”
Section: A B Discussionmentioning
confidence: 99%
“…Most studies on DRC are based on lymphocytes as the surrogate cell type (13,14 lymphocytes and upper aerodigestive tract epithelia, we included the two cell types in our investigations to further differentiate systemic and local effects (15). The aim of the study was to evaluate mutagen sensitivity and DRC in human lymphocytes and epithelial cells of the oropharynx of patients with and without squamous cell carcinoma (SCC) of the oropharynx.…”
Section: Introductionmentioning
confidence: 99%
“…Given the significant role of carcinogen exposure in these tumours, it proves difficult to study host factors related to cancer risk (Proia et al, 2006). Such studies are based on measurement of host DNA repair capacity, such as the bleomycin chromosome breakage assay (Wu et al, 1998;Rajaee-Behbahani et al, 2001), the host-cell reactivation assay (Diem and Runger, 1997), or the comet assay (Kleinsasser et al, 2000). These assays suggest host impairments in DNA repair, but they have found limited application in the clinical setting because they require intact cells, are labour intensive and may have limitations with respect to reproducibility (Berwick and Vineis, 2000).…”
mentioning
confidence: 99%
“…Kleinsasser et al reported, using an in vitro comet assay, that DNA damage (single-strand breaks) was signifi cantly induced by DIBP (354μmol/mL) in human oropharyngeal and nasal mucosa (32). In further work, Kleinsasser et al found that DIBP induced strand breaks in DNA, in both blood lymphocytes and normal mucosal cells from the oropharynx or larynx of patients of head and neck cancer (33).…”
Section: Discussionmentioning
confidence: 99%